Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Herpes Zoster (Shingles) : Muhammad Abdullah Dept. of Dermatology DHQ Hospital Faisalabad

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 26

Herpes Zoster (shingles)

Muhammad Abdullah
Dept. Of Dermatology DHQ Hospital
Faisalabad
INTRODUCTION

 Herpes zoster is an acute infectious viral disease.


 It is extremely painful and having incapacitating nature.
 It is characterised by inflammation of dorsal root ganglia or
extra-medullary cranial nerve ganglia , associated with
vesicular eruptions of the skin or mucous membrane in areas
supplied by sensory nerves.
VIRICELLA-Z0STER VIRUS (VZV ; HHV-3
)
 Viricella zoster virus is simillar to herpes simplex
virus(HSV) in many respects.

 Chicken pox represents the primary infection with VZV


latency ensures and recurrence is possible as HERPES
ZOSTER
 This disease is most common in adult life and affects male
and female with equal frequency.

 Although rare it does occur in children.

 The infection period is 10 - 21 days with an average of 15


days.
PREDISPOSING FACTORS FOR
REACTIVATION
 HIV infection
 Cytotoxic or treatment with immunosuppressive drugs
 Radiation
 Presence of malignancies
 Old age
 Alcohol abuse
 Stress ( emotional and physical)
 Dental manipulation
PATHOGENESIS
 After the initial infection with VZV ( chicken pox ), the virus
is transported up the sensory nerves and presumably
establishes latency in dorsal spinal ganglia.

 Simillar eosinophilic intra-nuclear inclusion bodies ,


indicative of viral infection occur in both the cases
 Herpes zoster rash has healed , a debilitating complications
known as post herpatic neuralgia(PHN).

 The incidense and severity of herpes zoster and PHN


increase with age in association with an age related decline in
cell-mediated immunity to VZV
CINICAL FEATURES
 It can be grouped into three phases
prodrome
acute
chronic
 During initial viral replication , active ganglionitis develops
with resultant neuronal necrosis and sever neuralgia
 As the virus travels down the nerve, pain intensifies and has
been described as burning, tingling, itching, boring, prickly,
or knifelike.
 Approximately 10% of affected individuals will exhibit no

pro-dermal pain.

 The pain may be


1) sensitive teeth

2) otitis media

3) migraine headache

4) myocardial infraction

5) appendicitis

 depending upon which dermatome is affected


ZOSTER SINE
 Conversely on occasion there may be recurrence in the
absence of vesiculation of the skin or mucosa.
 This pattern is called zoster sine (zoster with out rash)
 The acute phase begins as the involved skin develops clusters of

vesicles set on an erythmatous base.

 within 3 to 4 days the vesicles becomes pustular and ulcerate

with crusts developing after 7 to 10 days.


ORAL LESIONS
 Oral lesions occur with trigeminal nerve involvement and
may be present on the movable or bound mucosa.
 The lesions often extend to the mid-line and frequently are
present on conjuction with involvement of skin overlying the
affected quardant.
 Individual lesions manifest as 1 to 4 mm, white, opaque
vesicles that rupture to form shallow ulcerations.
 Involvement of maxilla may be associated with devitalization
of the teeth in the affected area.
 Several reports have documented significant bone necrosis
with loss of teeth in areas involved with herpes zoster.
 It is postulated that the gnathic osteonecrosis may be
secondary to damage of the blood vessels supplying the
alveolar ridges and teeth, leading to focal necrosis.
 Of the reported cases there is almost an equal distribution
between maxilla and mandible with both sexes similarly.
 Ocular involvement is not unusual and can be the source of
significant morbidity, including permanent blindness.
JAMES RAMSAY HUNT’S
SYNDROME
 A special form of zoster infection of the geniculate ganglion,
with the involvement of the external ear and oral mucosa,
has been termed hunte’s syndrome.
 Clinical manifestation
- facial paralysis
- pain of external auditory meatus and pinna of ear.
 vesicular eruption occur in oral cavity and oropharynx wth
hoarseness,tinnitus,vertigo and occasional oter disterbences.
ORAL MANIFESTATION
 Herpes zoster may involve the face by infection of trigeminal
nerve.
 This usually consist of unilateral involvement of skin areas
supplied by either the opthalmic , maxillary or mandibular
nerves.
 Lesions of the oral mucosa are fairly common , and
extremely painful vesicles may be found on the buccal
mucosa , tongue, uvula, pharynx and larynx.
 This generally rupture to leave areas of erosion.

 One of the characteristics clinical features of the disease

involving the face and oral cavity is the unilaterality of the


lesions.

 Typically, when large, the lesions will extend upto the

midline and stop abruptly


HISTOPATHOLOGIC
FEATURES
 The virus may cause acantholysis, the formation of numerous
free floating tzanck cells which exhibit nuclear margination
of chromatin and occasional multinucleaon.
Diagnosis
 Viral cultural can confirm the clinical impression but takes
atleast 24 hours.
 A rapid diagnosis can be obtain through the use of direct
staining of cytologic smears with fluorescent monoclonal
antibodies for VZV.
 This technique gives positive results in almost 80% of cases.
 Molecular techniques such as dotblot hybridization and PCR
also can be used to detect VZV.
Treatment and prognosis
 Fever should be treated with antipyretics that do not contain
aspirin.
 Antipruritic such as diphenhydramine can be administrated
to reduce etching.
 Early therapy with appropriate antiviral medications such as
acyclovir, valacyclovir and famciclovir has been found to
accelerate healing of the cutaneous and mucosal lesions.
 This medications are most effective if initiated within 72
hours after development of first vesicle.
 One topical treatment, capsaicin has had significant success
with 80% of patients.
 A live attenuated VZV vaccine has been approved for use in
adults, 60 years of age or older.
 Zostavax is 14 times more potent than varivax.

You might also like